The largest ever Italian biotech Series A round
NanoPhoria Bioscience secures €83.5 million Series A to advance breakthrough heart failure therapy
Spotlight on life sciences start-ups
Biotechnology
NanoPhoria S.r.l.
Founded in 2022 by Daniele Catalucci, Michele Iafisco, Alessio Alogna and Claudio De Luca NanoPhoria is a spin-off from Italy’s National Research Council (CNR). The company is developing a versatile, nano-in-micro & lung-to-heart delivery platform based on inorganic calcium phosphate ...
View start-up
Biotechnology
Tres Alchemix Co.Ltd.
Tres Alchemix is an AI-native biotechnology company developing a predictive drug-design platform to create next-generation small-molecule therapies. By integrating multi-omic and multimodal datasets with proprietary quantum-chemical calculation methods, it is building a human in silico model ...
View start-up
Diagnostics
FlareOn Biotech GmbH
FlareOn Biotech offers a new rapid tumor margin assessment tool for head and neck cancer directly in the operating room. Our patented sensor lights up in response to active biomarkers within removed tumor tissue, helping surgeons make critical decisions at the point of need to ensure complete ...
View start-up
Start-ups by industry
Loading...
Start-up News
Life sciences start-ups by country
More start-ups from other industries
Loading...